PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28206988-6	2017	Immunofluorescence analysis showed that 3-MA or Wort treatment reversed OGD-induced release of cathepsin B and L from the lysosome to the cytoplasm and activation of caspase-3 in the astrocytes.	3-methyladenine	40-44	cathepsin B	Rattus norvegicus	95-106	
21412169-7	2011	The redistribution of the lysosomal enzyme cathepsin B after injury was inhibited by 3-MA administered before ischemia, suggesting that this might be another important mechanism for the protective effect of 3-MA in ischemic neuronal injury.	3-methyladenine	85-89	cathepsin B	Rattus norvegicus	43-54	
21412169-7	2011	The redistribution of the lysosomal enzyme cathepsin B after injury was inhibited by 3-MA administered before ischemia, suggesting that this might be another important mechanism for the protective effect of 3-MA in ischemic neuronal injury.	3-methyladenine	207-211	cathepsin B	Rattus norvegicus	43-54	
18567942-10	2008	The neuroprotective effects of 3-MA and Z-FA-fmk were associated with an inhibition on ischemia-induced upregulation of LC3-II and cathepsin B and a partial reversion of ischemia-induced downregulation of cytoprotective Bcl-2.	3-methyladenine	31-35	cathepsin B	Rattus norvegicus	131-142	
18094625-6	2008	KA-induced increases in the ratio of LC3-II/LC3-I, LAMP2, cathepsin B, release of cytochrome c and activation of caspase-3 were blocked by pre-treatment with 3-MA.	3-methyladenine	158-162	cathepsin B	Rattus norvegicus	58-69	
25206520-8	2013	However, injection of 3-methyladenine significantly diminished light chain 3-II and cathepsin B expression.	3-methyladenine	22-37	cathepsin B	Rattus norvegicus	84-95